22 parallel-computing-numerical-methods Fellowship positions at University of Oxford in United-States
-
launched Oxford Programme for Cyber and Technology Policy (OxCTP). Reporting to the Co-Directors of OxCTP, you will manage your own academic research activities and collaborate in the preparation of research
-
About the role We have an exciting opportunity to join the Draper Group in the Department of Paediatrics as our Clinical Research Fellow – Malaria Vaccine Programme. This role is focused
-
The Oxford School of Global and Area Studies (OSGA) wishes to appoint a full- time fixed term Senior Research Fellow and Programme Manager in Taiwan Studies. About the Role: The postholder will be a
-
of genome organisation and metabolic control - with the bold vision of building synthetic life. In this role, you will develop and apply deep learning methods to analyse single-cell modalities, focusing
-
the University of Oxford, the postholder will conduct scientific research that refines existing methods, sheds light on the impacts of climate change in understudied regions, and informs adaptation and legal
-
, conducting evaluations and contributing to new methods development. PDRF: Lead cost-effectiveness evaluations, develop de novo economic models and new methods. SRF: As above with significant leadership
-
with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research Council (MRC), Wellcome Trust and National Institute
-
for candidates interested in acquiring experience of research in a world-class academic unit (see http://www.wrh.ox.ac.uk). The post supports a Phase III programme of work aimed at testing and validating
-
methods. You will be based in Radcliffe Primary Care on the Radcliffe Observatory Quarter in Oxford and report to the MS&HERG Operations Manager, Dr Angela Martin. Once established in the role, there may be
-
Translational Myeloma Centre (OTMC) is seeking to appoint a motivated and enthusiastic Clinical Research Fellow to join its dynamic and expanding programme of translational research in myeloma. This is an